Gene mutation profiling of breast cancers for clinical decision making: Drivers and passengers in the cart before the horse
Cet article passe en revue l'intérêt clinique des méthodes de séquençage à haut débit pour guider le choix d'un traitement chez des patientes atteintes d'un cancer du sein
Recent advances in molecular profiling allow for a rapid and relatively inexpensive assessment of multiple altered genes or gene products from small amounts of tumor tissues or blood. The challenge ahead is how to properly incorporate these results into clinical practice, and how to provide patients with the best possible yet evidence-based care. Herein, we provide a brief overview of genetic mutation profiling with a focus on next-generation sequencing (NGS) and possible clinical utility.
JAMA Oncology , article en libre accès, 2014